Founded in 2016, Maxwell Biosciences is a preclinical stage drug platform company actively developing an entirely new class of patented, virucidal, small molecule drugs called Claromers™. This novel drug class mimics natural antimicrobial peptides to safely and permanently inactivate viruses. Maxwell is led by a world-class team of scientists and experienced executives who are continuously innovating and submitting new paten...
Founded in 2016, Maxwell Biosciences is a preclinical stage drug platform company actively developing an entirely new class of patented, virucidal, small molecule drugs called Claromers™. This novel drug class mimics natural antimicrobial peptides to safely and permanently inactivate viruses. Maxwell is led by a world-class team of scientists and experienced executives who are continuously innovating and submitting new patent applications each month.
Sponsored Ad
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.